Related Experiment Video

Updated: Apr 12, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

13.1K

Are estradiol metabolites involved in gynaecological carcinogenesis?

Harald Seeger, Alfred O Mueck

    Hormone Molecular Biology and Clinical Investigation
    |May 12, 2015
    PubMed

    Insights

    Estradiol metabolites have varying potencies and potential roles in cancer. A lower ratio of 2-hydroxyestrone to 16α-hydroxyestrone is linked to reduced breast cancer risk.

    Area of Science:

    • Endocrinology and Metabolism
    • Oncology
    • Pharmacology

    Background:

    • Estradiol metabolites exhibit significant biological activity, sometimes exceeding that of estradiol itself.
    • Understanding oestrogenic effects requires analyzing the complete metabolite pattern using advanced laboratory techniques.
    • Current research investigates the anticancerogenic potential of 2-hydroxyestrone and 2-methoxyestradiol, alongside the carcinogenic concerns of 4-hydroxyoestrogens and 16α-hydroxyestrone.

    Purpose of the Study:

    • To explore the clinical relevance of estradiol metabolite activities, particularly in relation to malignancies.
    • To investigate the association between specific estradiol metabolite ratios and cancer risk, focusing on breast cancer.
    • To highlight the influence of lifestyle and clinical factors on estradiol metabolite production and interpretation.

    Main Methods:

    • Utilized sophisticated laboratory methods to analyze estradiol metabolite patterns.
    • Conducted clinical studies to assess the correlation between metabolite ratios and cancer risk.
    • Reviewed existing literature and internal data on estradiol metabolism in various cancers.

    Main Results:

    • Estradiol metabolite production is demonstrably altered in malignancies such as endometrial, breast, and cervical carcinomas.
    • Clinical studies revealed a significant negative correlation between the 2-hydroxyestrone to 16α-hydroxyestrone ratio and breast cancer risk.
    • In vitro and animal experiments suggest potential anticancerogenic and carcinogenic properties of specific estradiol metabolites, though clinical relevance is still under investigation.

    Conclusions:

    • The ratio of 2-hydroxyestrone to 16α-hydroxyestrone may serve as a biomarker for breast cancer risk.
    • Factors such as diet, physical activity, smoking, diseases, and medications critically influence estradiol metabolism and must be considered in study design and interpretation.
    • Further research is needed to clarify the precise clinical implications of estradiol metabolite patterns in cancer development and prevention.

    More Related Videos

    Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer10:36

    Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer

    Published on: March 17, 2016

    11.0K
    Prospecting Microbial Strains for Bioremediation and Probiotics Development for Metaorganism Research and Preservation09:49

    Prospecting Microbial Strains for Bioremediation and Probiotics Development for Metaorganism Research and Preservation

    Published on: October 31, 2019

    23.5K

    Related Concept Videos

    Oogenesis02:07

    Oogenesis

    In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
    71.5K
    Mutagenicity and Carcinogenicity01:25

    Mutagenicity and Carcinogenicity

    Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
    2.2K
    Transducer Mechanism: Nuclear Receptors01:31

    Transducer Mechanism: Nuclear Receptors

    Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
    About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
    6.3K
    Disorders of the Female Reproductive System01:24

    Disorders of the Female Reproductive System

    The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
    4.9K
    E2 Reaction: Stereochemistry and Regiochemistry02:43

    E2 Reaction: Stereochemistry and Regiochemistry

    Elimination reactions of alkyl halides can yield one or more alkenes depending on the specific regiochemical and stereochemical considerations. While the regiochemistry of the reaction governs the location of the double bond in the product, the stereochemical requirements often influence the geometry.
    When a substrate with two different β hydrogens undergoes an E2 elimination, the presence of a strong base can yield two regioisomeric alkenes. The more-substituted alkene is the major...
    14.9K